SCHEMBL2415235

SCHEMBL2415235

Nc1ccc(N2CCCC2CO)nc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADK P55263 1/20 0.43
CHUK O15111 2/20 0.43
CCNE1 P24864 3/20 0.41
CDK2 P24941 3/20 0.41
CCNE2 O96020 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
FPR2 P25090 1/20 0.40
SCN9A Q15858 1/20 0.40
PDE10A Q9Y233 1/20 0.40
PAK4 O96013 1/20 0.39
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
ADORA2A P29274 4/20 0.39
ADORA1 P30542 4/20 0.39
ADORA3 P0DMS8 2/20 0.39
ADORA2B P29275 1/20 0.39
ALOX5AP P20292 1/20 0.39
KLKB1 P03952 1/20 0.38
KLK1 P06870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2412675 0.87 CHUK (0.47) ADKCHUKCCNE1CDK2CCNE2
SCHEMBL2409885 0.83 CHUK (0.42) ADKCHUKCCNE1CDK2CCNE2
SCHEMBL2415080 0.82 ADORA2A (0.41) ADKCHUKCCNE1CDK2CCNE2
SCHEMBL2413848 0.82 CHUK (0.42) ADKCHUKCCNE1CDK2CCNE2
SCHEMBL2413665 0.82 CHUK (0.39) ADKCHUKCCNE1CDK2CCNE2
SCHEMBL2415698 0.80 CHUK (0.40) ADKCHUKCCNE1CDK2CCNE2
SCHEMBL2410711 0.80 ADK (0.41) ADKCHUKCCNE1CDK2CCNE2
SCHEMBL2415018 0.80 CHUK (0.43) ADKCHUKFPR2SCN9AMKNK1
SCHEMBL2411682 0.80 PDE10A (0.40) ADKCHUKCCNE1CDK2CCNE2
SCHEMBL14890705 0.79 SYK (0.44) ADKCHUKCCNE1CDK2CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP claimed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US claimed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US claimed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP claimed
EP-1312606-B1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres OREAL (FR) 2011-09-21 EP disclosed
US-6837908-B2 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2005-01-04 US disclosed
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres L'OREAL S.A. (FR) 2003-09-04 US disclosed
EP-1312606-A1 2,5-diaminopyridine oxidation bases and their use for dyeing of keratin fibres L'OREAL (FR) 2003-05-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030163876-A1 Novel 2,5-diaminopyridine oxidation bases for the dyeing of keratin fibres KRT18, DPYD, DSP ADK 2958/4885CHUK 4002/4885CCNE1 3807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.